- Release Date: 17/02/16 08:30
- Summary: GENERAL: CRP: Ombudsman to investigate EPA Chatham application treatment
- Price Sensitive: No
- Download Document 1.45KB
CRP 17/02/2016 08:30 GENERAL NOT PRICE SENSITIVE REL: 0830 HRS Chatham Rock Phosphate Limited GENERAL: CRP: Ombudsman to investigate EPA Chatham application treatment Chatham Rock Phosphate Limited Market announcement 16 February 2016 Ombudsman agrees to investigate EPA handling of Chatham's application for a marine consent Chatham Rock Phosphate advised on 3 December 2015 that it intended to oppose an application for summary judgment for costs relating to the marine consent hearing process, made by the Environmental Protection Authority. The EPA is seeking payment of just under $800,000 of invoiced but unpaid costs. CRP subsequently made a request to the Office of the Ombudsman to conduct a formal investigation into the EPA's charges. The requested scope of the investigation was first to examine the EPA's costs recovery practices for its marine consent process - including the withholding of information from CRP which was relevant to whether some of the charges were authorised by law. In January we were asked by the Ombudsman to provide further information and to clarify certain matters. We are now able to report that we have been advised by the Office of the Ombudsman that they will be conducting an investigation into the matters we have raised. CRP welcomes this investigation. Chris Castle CEO - Chatham Rock Phosphate Ltd +64 (21) 558 185 [email protected] Skype: phosphateking End CA:00277730 For:CRP Type:GENERAL Time:2016-02-17 08:30:10
- Forums
- NZX - By Stock
- CRP
- Ann: GENERAL: CRP: Ombudsman to investigate EPA Chatham application treatment
CRP
chatham rock phosphate limited
Add to My Watchlist
0.00%
!
9.3¢

Ann: GENERAL: CRP: Ombudsman to investigate EPA Chatham application treatment
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
The Watchlist
PSC
PROSPECT RESOURCES LIMITED
Sam Hosack, MD & CEO
Sam Hosack
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online